163 related articles for article (PubMed ID: 29964005)
21. Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.
Reine PA; Vethe NT; Kongsgaard UE; Andersen AM; Line PD; Ali AM; Bergan S
Scand J Clin Lab Invest; 2013 Mar; 73(2):117-24. PubMed ID: 23281843
[TBL] [Abstract][Full Text] [Related]
22. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.
Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745
[TBL] [Abstract][Full Text] [Related]
23. Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients.
Smits TA; Cox S; Fukuda T; Sherbotie JR; Ward RM; Goebel J; Vinks AA
Ther Drug Monit; 2014 Dec; 36(6):716-23. PubMed ID: 24739663
[TBL] [Abstract][Full Text] [Related]
24. Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation.
Rath T; Küpper M
Transplant Proc; 2009; 41(6):2524-8. PubMed ID: 19715967
[TBL] [Abstract][Full Text] [Related]
25. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT; de Winter BC; Hesselink DA; Sombogaard F; Wang LL; van Gelder T
Br J Clin Pharmacol; 2017 Apr; 83(4):812-822. PubMed ID: 27753146
[TBL] [Abstract][Full Text] [Related]
26. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
[TBL] [Abstract][Full Text] [Related]
27. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
[TBL] [Abstract][Full Text] [Related]
29. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.
Daxecker H; Raab M; Müller MM
Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.
Glander P; Sommerer C; Arns W; Ariatabar T; Kramer S; Vogel EM; Shipkova M; Fischer W; Zeier M; Budde K
Clin J Am Soc Nephrol; 2010 Mar; 5(3):503-11. PubMed ID: 20150450
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.
Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC
Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488
[TBL] [Abstract][Full Text] [Related]
33. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.
Vethe NT; Bremer S; Rootwelt H; Bergan S
Ther Drug Monit; 2008 Dec; 30(6):647-55. PubMed ID: 18806697
[TBL] [Abstract][Full Text] [Related]
35. Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.
Sanquer S; Maison P; Tomkiewicz C; Macquin-Mavier I; Legendre C; Barouki R; Lang P
Clin Pharmacol Ther; 2008 Feb; 83(2):328-35. PubMed ID: 17713475
[TBL] [Abstract][Full Text] [Related]
36. The combination of exposure to Tacrolimus, mycophenolic acid, Inosine 5'-Monophosphate Dehydrogenase activity and inhibition in the first week define early histological outcomes in renal transplant recipients.
Thanukrishnan H; Venkataramanan R; Mehta RB; Jorgensen D; Sood P
Clin Transplant; 2022 Dec; 36(12):e14830. PubMed ID: 36177865
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of mycophenolic acid in Nagase analbuminemic rats: Evaluation of protein binding effects using the modeling and simulation approach.
Yoshimura K; Yano I; Kawanishi M; Nakagawa S; Yonezawa A; Matsubara K
Drug Metab Pharmacokinet; 2015 Dec; 30(6):441-8. PubMed ID: 26643991
[TBL] [Abstract][Full Text] [Related]
38. Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Glander P; Braun KP; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer HH; Budde K
Clin Biochem; 2001 Oct; 34(7):543-9. PubMed ID: 11738390
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients.
Molinaro M; Chiarelli LR; Biancone L; Castagneto M; Boschiero L; Pisani F; Sabbatini M; Sandrini S; Arbustini E; Tinelli C; Regazzi M; Schena FP; Segoloni GP
Drug Metab Pharmacokinet; 2013; 28(2):109-17. PubMed ID: 22892445
[TBL] [Abstract][Full Text] [Related]
40. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
